2.82
price up icon0.00%   0.00
pre-market  Pre-mercato:  2.81   -0.010   -0.35%
loading
Precedente Chiudi:
$2.82
Aprire:
$2.79
Volume 24 ore:
1.45M
Relative Volume:
1.48
Capitalizzazione di mercato:
$254.55M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-2.5405
EPS:
-1.11
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
-9.03%
1M Prestazione:
-0.70%
6M Prestazione:
-32.54%
1 anno Prestazione:
-6.00%
Intervallo 1D:
Value
$2.76
$2.89
Intervallo di 1 settimana:
Value
$2.735
$3.255
Portata 52W:
Value
$1.90
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
Nome
Codexis Inc
Name
Telefono
650-421-8100
Name
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Dipendente
188
Name
Cinguettio
@codexisinc
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
CDXS's Discussions on Twitter

Confronta CDXS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CDXS
Codexis Inc
2.82 270.80M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.46 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
598.16 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
467.55 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
663.73 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.97 37.96B 3.81B -644.79M -669.77M -6.24

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-19 Downgrade The Benchmark Company Buy → Hold
2024-06-03 Ripresa Jefferies Buy
2024-05-30 Iniziato Cantor Fitzgerald Overweight
2024-02-29 Aggiornamento The Benchmark Company Hold → Buy
2023-11-07 Downgrade The Benchmark Company Buy → Hold
2023-08-07 Downgrade TD Cowen Outperform → Market Perform
2023-05-09 Downgrade H.C. Wainwright Buy → Neutral
2022-03-31 Ripresa Piper Sandler Overweight
2022-03-02 Ripresa Cowen Outperform
2021-04-12 Iniziato Piper Sandler Overweight
2021-03-01 Iniziato Stifel Buy
2021-02-26 Reiterato H.C. Wainwright Buy
2020-03-10 Iniziato The Benchmark Company Buy
2019-01-17 Aggiornamento First Analysis Sec Neutral → Outperform
2018-05-16 Iniziato Stephens Overweight
2017-10-13 Reiterato H.C. Wainwright Buy
2017-05-31 Iniziato Jefferies Buy
2017-01-26 Downgrade First Analysis Sec Overweight → Equal-Weight
2017-01-04 Aggiornamento Ladenburg Thalmann Neutral → Buy
2016-01-06 Iniziato H.C. Wainwright Buy
Mostra tutto

Codexis Inc Borsa (CDXS) Ultime notizie

pulisher
Aug 19, 2025

Codexis Inc.’s Price Action Aligns with Quant Signals2025 Pullback Review & Weekly High Potential Alerts - thegnnews.com

Aug 19, 2025
pulisher
Aug 19, 2025

Benchmark reiterates Hold rating on Codexis stock after Q2 results - Investing.com

Aug 19, 2025
pulisher
Aug 18, 2025

Momentum Screeners Rank Codexis Inc. in Top 5 TodayJuly 2025 Recap & Free Community Supported Trade Ideas - 선데이타임즈

Aug 18, 2025
pulisher
Aug 18, 2025

Institutional Tools Highlight Unusual Flow in Codexis Inc.2025 Technical Overview & Fast Entry Momentum Alerts - 선데이타임즈

Aug 18, 2025
pulisher
Aug 17, 2025

Codexis, Inc. (NASDAQ:CDXS) Q2 2025 Earnings Call Transcript - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

Statistical indicators supporting Codexis Inc.’s strengthWeekly Risk Report & AI Forecast for Swing Trade Picks - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Does Codexis Inc. show high probability of reboundQuarterly Earnings Report & Low Risk High Reward Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Can a trend reversal in Codexis Inc. lead to recoveryEarnings Summary Report & Accurate Entry/Exit Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What to expect from Codexis Inc. in the next 30 daysJuly 2025 Recap & AI Powered Market Trend Analysis - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Short interest data insights for Codexis Inc.Trade Entry Summary & Advanced Swing Trade Entry Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Risk adjusted return profile for Codexis Inc. analyzedM&A Rumor & High Accuracy Swing Trade Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Quantitative breakdown of Codexis Inc. recent moveSwing Trade & Risk Managed Investment Strategies - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Codexis Inc. Recovery Potential Based on Technical ToolsBull Run & Daily Volume Surge Trade Alerts - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Codexis Revenue Jumps 91 Percent in Q2 - AOL.com

Aug 16, 2025
pulisher
Aug 16, 2025

Can Codexis Inc. Bounce Back From Weekly LowJuly 2025 Price Swings & Low Risk Growth Stock Ideas - classian.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Codexis reiterates $64M–$68M 2025 revenue guidance while exploring ECO Synthesis expansion - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Chart overlay techniques for tracking Codexis Inc.GDP Growth & Verified Trade Idea Suggestions - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Codexis Inc. stock ready for a breakoutWeekly Market Report & Low Risk Entry Point Guides - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Codexis (NASDAQ:CDXS) Upgraded by Wall Street Zen to Hold Rating - Defense World

Aug 16, 2025
pulisher
Aug 15, 2025

Price Channel Expanding on Codexis Inc.’s ChartM&A Rumor & Weekly Hot Stock Watchlists - 선데이타임즈

Aug 15, 2025
pulisher
Aug 15, 2025

Full technical analysis of Codexis Inc. stockJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Sector ETF performance correlation with Codexis Inc.Bull Run & Real-Time Chart Breakout Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Codexis Inc. Nearing Breakout Level After BounceWeekly Profit Analysis & Stepwise Trade Execution Plans - beatles.ru

Aug 15, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 21:26:42 - newsimpact.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Codexis Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 15, 2025
pulisher
Aug 15, 2025

Codexis Inc. Stock Performance After Earnings: Historical InsightsJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Exceeds Q2 2025 Revenue Expectations, Raises $27.3M for ECO Synthesis Expansion - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Holdings: A Promising Future Amid Capacity Uncertainties - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Stifel maintains Buy rating on Codexis stock amid strong business outlook - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Cantor Fitzgerald reiterates Overweight rating on Codexis stock, maintains $11 price target - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis shares rise 11.48% premarket after reporting strong Q2 revenue and raising $27.3M for ECO Synthesis expansion. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Stock Soars 11.48% on Q2 Earnings Beat - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Q2 rev. $15.3mln, up YoY, raises $27.3mln for ECO Synthesis expansion. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis 2025 Q2 Earnings 41.7% Net Loss Reduction - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis: Q2 Earnings Snapshot - Greenwich Time

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Delivers Strong Q2 ResultsCan The Stock Rebound? - RTTNews

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Inc (CDXS) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Initiatives - Yahoo Finance

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Inc. Stock Support and Resistance Levels You Should KnowInflation Watch & Target Return Focused Picks - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Codexis Surpasses Expectations with Strong Q2 2025 Results - TipRanks

Aug 14, 2025
pulisher
Aug 13, 2025

Codexis Q2 2025: Navigating Contradictions in Revenue Growth, Lab Expansion, and Partnering Strategies - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Transcript : Codexis, Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener

Aug 13, 2025
pulisher
Aug 13, 2025

Codexis, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:CDXS) - Seeking Alpha

Aug 13, 2025
pulisher
Aug 13, 2025

Earnings call transcript: Codexis Q2 2025 beats EPS expectations, stock surges - Investing.com Nigeria

Aug 13, 2025
pulisher
Aug 13, 2025

Codexis Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

Codexis Q2 2025 slides: revenue surges 91%, operating loss narrows significantly By Investing.com - Investing.com South Africa

Aug 13, 2025
pulisher
Aug 13, 2025

Codexis Inc (CDXS) Q2 2025 Earnings: Revenue Surpasses Estimates at $15.3 Million, EPS Details Awaited - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

Codexis earnings beat by $0.03, revenue topped estimates - Investing.com Canada

Aug 13, 2025
pulisher
Aug 13, 2025

Codexis Reports Strong Q2 2025 Revenue of $15.3M and Expands ECO Synthesis® Platform Commitments - Quiver Quantitative

Aug 13, 2025
pulisher
Aug 13, 2025

Codexis Reports Second Quarter 2025 Financial Results - The Manila Times

Aug 13, 2025

Codexis Inc Azioni (CDXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Codexis Inc Azioni (CDXS) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Opaleye Management Inc.
10% Owner
Aug 04 '25
Buy
2.83
780
2,211
12,545,000
Opaleye Management Inc.
10% Owner
Jul 29 '25
Buy
2.82
8,422
23,750
12,458,422
Opaleye Management Inc.
10% Owner
Jul 30 '25
Buy
2.79
1,578
4,411
12,460,000
Opaleye Management Inc.
10% Owner
Jul 18 '25
Buy
2.82
100,000
282,000
12,450,000
Opaleye Management Inc.
10% Owner
Jun 27 '25
Buy
2.39
100,000
239,000
12,350,000
Opaleye Management Inc.
10% Owner
Jun 12 '25
Buy
2.25
100,000
225,000
12,100,000
Opaleye Management Inc.
10% Owner
Jun 13 '25
Buy
2.23
99,102
220,997
12,199,102
Opaleye Management Inc.
10% Owner
Jun 16 '25
Buy
2.24
50,898
114,012
12,250,000
Opaleye Management Inc.
10% Owner
May 23 '25
Buy
2.36
2,320,000
5,475,200
11,995,000
Opaleye Management Inc.
10% Owner
May 28 '25
Buy
2.36
5,000
11,800
12,000,000
$36.31
price down icon 1.55%
$86.53
price up icon 0.38%
$26.01
price up icon 0.54%
$110.77
price down icon 0.48%
$132.60
price up icon 2.43%
biotechnology ONC
$313.97
price up icon 1.50%
Capitalizzazione:     |  Volume (24 ore):